October 31, 2016
Allergan’s chronic dry eye drops will make patients shed more tears
Allergan has received approval from the FDA for Restasis, treatment to help patients with a type of Chronic Dry Eye …
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Allergan
October 27, 2016
Allergan to close down buying Motus, relamorelin goes to Phase 3 tests
Allergan on Thursday announced the results of Phase 2b study of the new gastroparesis…
October 27, 2016
Allergan: changes to board leadership
Allergan has announced changes to leadership roles within its board of directors.
October 25, 2016
Allergan completes acquisition of Vitae
Allergan successfully completed its tender offer to purchase …
October 19, 2016
Allergan releases its “lip pumping drug” to the US market
Allergan has announced that the latest addition to the Juvederm collection of fillers, Juvederm Volbella XC, is now available to physicians and patients for use in the lips for lip augmentation and for correction of perioral rhytids, commonly referred to as “lipstick lines”, in adults over the age of 21.
October 18, 2016
Teva buys Anda from Allergan
Teva Pharmaceutical Industries, an NYSE and TASE listed pharmaceutical company has completed its acquisition of Anda, Inc., a distributor of…
October 14, 2016
Allergan partners with SonarMD in developing new IBS-D patient engagement platform
Allergan has announced a collaboration with SonarMD on the development of clinical decision support (CDS) and patient engagement tools which can be used to facilitate physician identification of patients suffering from Irritable Bowel Syndrome with Diarrhea (IBS-D) in clinical practice and monitor their treatment outcomes.
October 13, 2016
Allergan’s BELKYRA Receives Marketing Authorisation In Sweden
Allergan announced that Sweden has received the Marketing Authorisation for BELKYRA (deoxycholic acid) after being granted approval by the Swedish Medical Products Agency (MPA).
October 12, 2016
Inspirational Portraits And Interviews Of Famous Women in Allergan’s ActuallySheCan campaign
ActuallySheCanSM, the female empowerment campaign by Allergan, has unveiled a striking series of portraits shot by celebrated photographers Inez van…
April 8, 2016
Allergan and Heptares team up for novel treatments in Alzheimer’s
Allergan and Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation have entered into an agreement under which Allergan will license exclusive global rights to a broad portfolio of novel subtype-selective muscarinic receptor agonists in development for the treatment of major neurological disorders, including Alzheimer’s disease.